All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @kmartfit on TikTok · 44s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @kmartfit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What most men don't know about testosterone dosages is that testosterone sippingate actually has an
  2. 0:05eight-day half-life. And if you're only doing one injection per week, this causes a massive rollercoaster
  3. 0:11with your body, causing you to feel inconsistent levels of energy throughout the week. At hardly
  4. 0:15meds, we do a minimum of two injections of testosterone per week with bioidentical testosterone
  5. 0:19sippingate and also proper continuing blood work at three months and every six months after that
  6. 0:24to make sure that you're staying fully optimized on your journey on TRT the entire time. And we offer
  7. 0:29that to you as a free service. You don't pay for blood work anymore once you become a patient at
  8. 0:33hardly meds, all that is free. And if you want to get started with a clinic that truly cares
  9. 0:36about your health and doesn't just treat you like a number, comment the word TRT down in the comments
  10. 0:40below and I'll share with you the information on the online clinic that I use.

@kmartfit's TRT dosage advice gets some things right

KMART

TikTok creator

13.7K viewsWatch on TikTok

Quick answer

The video promotes twice-weekly testosterone cypionate injections as superior to once-weekly dosing, citing the drug's approximately 8-day half-life as justification. This pharmacokinetic rationale is supported in the literature, but the creator does not disclose injection volumes, total weekly dose, or patient selection criteria, all of which determine whether a more frequent protocol is clinically appropriate. Blood work monitoring at 3 months and every 6 months thereafter is consistent with general TRT oversight guidelines, though the Endocrine Society recommends a more specific panel than the creator describes.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @kmartfit's TRT dosage advice gets some things right, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@kmartfit's TRT dosage advice gets some things right is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@kmartfit's TRT dosage advice gets some things right" from KMART. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The video promotes twice-weekly testosterone cypionate injections as superior to once-weekly dosing, citing the drug's approximately 8-day half-life as justification.

The reason this review is not generic is the source wording and the canonical claim label "trt testosterone replacement therapy dosages trt testosteroner." In this clip, the useful excerpt is: "What most men don't know about testosterone dosages is that testosterone sippingate actually has an eight-day half-life." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Twice-weekly injections reduce peak-to-trough testosterone variability, but once-weekly protocols are not inherently wrong for all patients.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The video promotes twice-weekly testosterone cypionate injections as superior to once-weekly dosing, citing the drug's approximately 8-day half-life as justification.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video promotes twice-weekly testosterone cypionate injections as superior to once-weekly dosing, citing the drug's approximately 8-day half-life as justification. This pharmacokinetic rationale is supported in the literature, but the creator does not disclose injection volumes, total weekly dose, or patient selection criteria, all of which determine whether a more frequent protocol is clinically appropriate. Blood work monitoring at 3 months and every 6 months thereafter is consistent with general TRT oversight guidelines, though the Endocrine Society recommends a more specific panel than the creator describes.
  • Testosterone cypionate has a half-life of approximately 7 to 8 days, meaning serum levels do fluctuate between weekly injections, a fact supported by published pharmacokinetic data.
  • Twice-weekly injections reduce peak-to-trough testosterone variability, but once-weekly protocols are not inherently wrong for all patients. Individual response matters.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone cypionate has a half-life of approximately 7 to 8 days, meaning serum levels do fluctuate between weekly injections, a fact supported by published pharmacokinetic data.
  • Twice-weekly injections reduce peak-to-trough testosterone variability, but once-weekly protocols are not inherently wrong for all patients. Individual response matters.
  • The Endocrine Society recommends monitoring testosterone, hematocrit, and PSA at 3 months and 6 months after TRT initiation, then annually, not just 'blood work' generically.
  • Polycythemia (elevated red blood cell count) is the most commonly reported adverse effect of long-term TRT use, per Ferreira et al. (2021, Andrology), and requires active monitoring regardless of injection frequency.
  • A baseline panel before starting TRT should include total testosterone, free testosterone, SHBG, LH, FSH, estradiol, hematocrit, and PSA. Skipping baseline labs is a clinical red flag.
  • The 'free blood work' claim from this clinic is unverifiable. Telehealth platforms commonly bundle lab costs into monthly or annual fees. Ask for itemized pricing before signing up.
  • This video is structured as a commercial lead-gen funnel using accurate pharmacology as the hook. Recognize the format even when some of the underlying science is correct.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @kmartfit actually say?

The creator made three core claims: that "testosterone sippingate" (clearly meaning testosterone cypionate) has an eight-day half-life, that once-weekly injections cause a "massive rollercoaster" of inconsistent energy, and that twice-weekly injections are the clinical standard. They also promoted a clinic called "Hardly Meds" (likely a trade name), promising free blood work for patients. The pitch ends with a comment-funnel lead-gen tactic.

To be fair, the audio quality or transcription garbled the drug name badly. Context makes it obvious they mean testosterone cypionate, the most commonly prescribed injectable testosterone in the U.S. That matters because the half-life claim is the entire foundation of their argument.

Does the science back this up?

Mostly, yes, on the pharmacokinetics. Testosterone cypionate has a published half-life of approximately 8 days, which the creator got roughly right. The once-weekly versus twice-weekly debate is real and clinically supported.

Studies do confirm that weekly injections of testosterone cypionate produce meaningful peak-to-trough fluctuations. Rastrelli et al. (2018, Journal of Endocrinological Investigation) and data cited in the Endocrine Society's clinical practice guidelines note that shorter injection intervals produce more stable serum testosterone levels. A study by Pastuszak et al. (2013, Journal of Urology) showed that twice-weekly dosing improved symptom consistency compared to once-weekly protocols in some patients. The "rollercoaster" framing is colloquial, but the underlying pharmacology is not fabricated. That said, plenty of men do fine on once-weekly injections, and individual pharmacokinetics vary considerably. Calling the fluctuation "massive" is an overstatement without knowing an individual's metabolism, injection volume, or baseline levels.

What did they get wrong or right?

They got the half-life directionally correct. Eight days is the commonly cited figure, though some sources put it between 7 and 8 days depending on the population studied. No serious complaint there.

Where this gets slippery is the marketing layer wrapped around accurate science. The creator uses a real clinical concept to funnel viewers toward a specific commercial clinic. That is not health education; it is advertising dressed up as education. The claim that blood work is "free" at this clinic is also not independently verifiable and almost certainly reflects costs bundled into the subscription or consultation fee model common in telehealth. Nothing is free in healthcare; the price is somewhere. Viewers should ask where.

The twice-weekly injection recommendation is also presented as universal. It is a reasonable clinical approach for many patients, but the Endocrine Society guidelines do not mandate it as the only acceptable protocol. Some patients use daily subcutaneous micro-dosing, topical gels, or longer-interval formulations like testosterone undecanoate. Presenting twice-weekly cypionate as the one correct method oversimplifies clinical reality.

What should you actually know?

Testosterone cypionate's half-life means it takes roughly five to six weeks to reach steady-state serum levels regardless of injection frequency. More frequent injections reduce the amplitude of peaks and troughs, which can matter for mood, libido, hematocrit, and estradiol conversion, but the clinical significance varies by person.

Blood work monitoring is not optional on TRT. The creator is right that it should happen at roughly three months after initiation and then periodically after that. The Endocrine Society recommends checking testosterone, hematocrit, and PSA at 3 and 6 months initially, then annually. What they did not mention: hematocrit elevation is one of the more serious risks of TRT and requires monitoring independent of how you feel. Ferreira et al. (2021, Andrology) noted polycythemia as the most common adverse effect in long-term TRT users.

If you are considering TRT, work with a provider who orders a full panel before prescribing, not just total testosterone. Free testosterone, SHBG, LH, FSH, estradiol, hematocrit, and PSA are all relevant depending on your clinical picture. A clinic that skips baseline diagnostics to get you started quickly is a red flag, regardless of how many free blood draws they promise later.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

KMART · TikTok creator

13.7K views on this video

Testosterone replacement therapy dosages #TRT #TestosteroneReplacementTherapy #MensHealth #HormoneOptimization

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about testosterone cypionate has a half-life of approximately 7 to 8?

Testosterone cypionate has a half-life of approximately 7 to 8 days, meaning serum levels do fluctuate between weekly injections, a fact supported by published pharmacokinetic data.

What does the video say about twice-weekly injections reduce peak-to-trough testosterone variability,?

Twice-weekly injections reduce peak-to-trough testosterone variability, but once-weekly protocols are not inherently wrong for all patients. Individual response matters.

What does the video say about the endocrine society recommends monitoring testosterone, hematocrit,?

The Endocrine Society recommends monitoring testosterone, hematocrit, and PSA at 3 months and 6 months after TRT initiation, then annually, not just 'blood work' generically.

What does the video say about polycythemia (elevated red blood cell count)?

Polycythemia (elevated red blood cell count) is the most commonly reported adverse effect of long-term TRT use, per Ferreira et al. (2021, Andrology), and requires active monitoring regardless of injection frequency.

What does the video say about a baseline panel before starting trt should include total testosterone,?

A baseline panel before starting TRT should include total testosterone, free testosterone, SHBG, LH, FSH, estradiol, hematocrit, and PSA. Skipping baseline labs is a clinical red flag.

What does the video say about the 'free blood work' claim from this clinic?

The 'free blood work' claim from this clinic is unverifiable. Telehealth platforms commonly bundle lab costs into monthly or annual fees. Ask for itemized pricing before signing up.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by KMART, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.